Browsing by Author Matthews, Gail

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2013Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with menHillman, Richard; Botes, Leon P; Carbone, Sonia; Carr, Andrew D.; Cooper, David; Kumaradevan, Nirmala; Marriott, Debbie; Matthews, Gail; McHugh, Leo; Pett, Sarah; Western Clinical School: Medicine (Westmead)Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with men, Sexual Health, vol.10, 1, 2013,pp 9-17
2017Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: Analysis of national sentinel surveillance dataO'Connor, Catherine Cecilia; Boettiger, David; Callander, Denton; Donovan, Basil; Dore, Gregory; Fairley, Christopher K.; Guy, Rebecca; Hellerd, Margaret; Law, Matthew; Matthews, Gail; School of Public Health: Public HealthHepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: Analysis of national sentinel surveillance data, BMC Infectious Diseases, vol.17, 1, 2017,pp 1-12
2015Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis CDay, Carolyn; Haber, Paul; Alavi, Maryam; Bruneau, Julie; Dolan, Kate; et al, Various; Kaldor, John M; Matthews, Gail; Petoumenos, Kathy; Spelman, Tim; Van Beek, Ingrid; Walsh, Nick; Yeung, Barbara; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineInjecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C, International Journal of Drug Policy, vol.26, 10, 2015,pp 976-983
2016Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDouglas, Mark; George, Jacob; Sheridan, David; Applegate, Tanya; Askew, Ben; Dore, Gregory J.; et al, .; Fenwick, Fiona; Hajarizadeh, Behzad; Matthews, Gail; Neely, Dermot; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResMaximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection, Liver International, vol.36, 12, 2016,pp 1774-1782
2016Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDouglas, Mark; George, Jacob; Sheridan, David; Applegate, Tanya; Askew, Ben; Dore, Gregory J.; et al, .; Fenwick, Fiona; Hajarizadeh, Behzad; Matthews, Gail; Neely, Dermot; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResMaximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection, Liver International, vol.36, 12, 2016,pp 1774-1782
2013Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infectionGeorge, Jacob; Applegate, Tanya; Bruneau, Julie; Cherepanov, Vera; Dore, Gregory; Feld, Jordan; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew; Matthews, Gail; Petoumenos, Kathy; Shaw, Ineke; Sherker, Alana; Shoukry, Naglaa H.; Teutsch, Suzy; Yeung, Barbara; Zang, Geng; Western Clinical School: Westmead Millennium InstitutePlasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection, Hepatology, vol.57, 6, 2013,pp 2124-2134
2016Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studiesHaber, Paul; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Iser, David M.; Lloyd, Andrew; Maire, Laurence; Martinello, Marianne; Matthews, Gail; Petoumenos, Kathy; Sasadeusz, J; Shaw, David R; Thompson, Alexander; Yeung, Barbara; Central Clinical School: Addiction MedicineShort duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies, Antiviral Therapy, vol.21, 5, 2016,pp 425-434
2016Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studiesHaber, Paul; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Iser, David M.; Lloyd, Andrew; Maire, Laurence; Martinello, Marianne; Matthews, Gail; Petoumenos, Kathy; Sasadeusz, J; Shaw, David R; Thompson, Alexander; Yeung, Barbara; Central Clinical School: Addiction MedicineShort duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies, Antiviral Therapy, vol.21, 5, 2016,pp 425-434
2016Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014)George, Jacob; Alavi, Maryam; Amin, Janaki; Dore, Gregory J.; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Matthews, Gail; Waziry, Reem; Western Clinical School: Westmead Institute for Medical ResTrends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014), Journal of Hepatology, vol.65, 6, 2016,pp 1086-1093